| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(18)30064-1 |
| P698 | PubMed publication ID | 29395997 |
| P50 | author | Brian Greenwood | Q4963885 |
| Christopher Pell | Q54802142 | ||
| Patrick Walker | Q56342189 | ||
| Jenny Hill | Q61170626 | ||
| Kassoum Kayentao | Q72251479 | ||
| Meghna Desai | Q86868973 | ||
| Jayne Webster | Q93638147 | ||
| P2093 | author name string | Michel Cot | |
| Julie Gutman | |||
| Feiko O Ter Kuile | |||
| Raquel Gonzalez | |||
| Silke Fernandes | |||
| P2860 | cites work | Reply to Harrington et al | Q56530355 |
| Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting | Q43063426 | ||
| Defending the Use of Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment for Malaria in Pregnancy: A Short-Sighted Strategy | Q43101121 | ||
| Systemic constraints continue to limit coverage of intermittent preventive treatment for malaria in pregnancy in southeast Tanzania | Q43936397 | ||
| Treatment of Malaria in Pregnancy | Q44027352 | ||
| Cost-effectiveness of adding bed net distribution for malaria prevention to antenatal services in Kinshasa, Democratic Republic of the Congo. | Q44147690 | ||
| Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi | Q46126630 | ||
| Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study | Q46364500 | ||
| The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. | Q46571385 | ||
| HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment | Q46858258 | ||
| Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials | Q47844653 | ||
| A double-blind randomized therapeutic trial of insect repellents for the prevention of malaria in pregnancy | Q47883135 | ||
| Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'. | Q48013127 | ||
| Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem | Q50207341 | ||
| Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | Q21133667 | ||
| Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis | Q26795623 | ||
| Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis | Q26849714 | ||
| Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis | Q27010263 | ||
| The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis | Q28471972 | ||
| Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique | Q28475795 | ||
| Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring | Q28486791 | ||
| Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial | Q28543146 | ||
| Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial | Q28543154 | ||
| Access and use of interventions to prevent and treat malaria among pregnant women in Kenya and Mali: a qualitative study | Q28544824 | ||
| Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy | Q28546725 | ||
| Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized [...] | Q28554025 | ||
| Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials | Q28763143 | ||
| Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11. | Q30668656 | ||
| Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data | Q30896993 | ||
| Feasibility and coverage of implementing intermittent preventive treatment of malaria in pregnant women contacting private or public clinics in Tanzania: experience-based viewpoints of health managers in Mkuranga and Mufindi districts | Q31140413 | ||
| Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections | Q33589254 | ||
| Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine | Q33601831 | ||
| Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas | Q33754488 | ||
| Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial | Q33784329 | ||
| Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability | Q34009795 | ||
| Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin | Q34322250 | ||
| Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial | Q34341776 | ||
| Cost-effectiveness analysis of three health interventions to prevent malaria in pregnancy in an area of low transmission in Uganda | Q34343139 | ||
| Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region | Q39229580 | ||
| Malaria in pregnancy: challenges for control and the need for urgent action | Q39245562 | ||
| Minimal Impact by Antenatal Subpatent Plasmodium falciparum Infections on Delivery Outcomes in Malawian Women: A Cohort Study. | Q39514602 | ||
| Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. | Q39569746 | ||
| Perception and affordability of long-lasting insecticide-treated nets among pregnant women and mothers of children under five years in Ogun State, Nigeria | Q41731699 | ||
| Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial | Q41943572 | ||
| The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana | Q34558411 | ||
| Factors affecting providers' delivery of intermittent preventive treatment for malaria in pregnancy: a five-country analysis of national service provision assessment surveys | Q34587008 | ||
| Prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali: a quantitative health systems effectiveness analysis | Q34807564 | ||
| A qualitative health systems effectiveness analysis of the prevention of malaria in pregnancy with intermittent preventive treatment and insecticide treated nets in Mali | Q34812010 | ||
| Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women | Q34974794 | ||
| Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial | Q35008674 | ||
| Effectiveness of antenatal clinics to deliver intermittent preventive treatment and insecticide treated nets for the control of malaria in pregnancy in Mali: a household survey | Q35126049 | ||
| Preventing malaria in pregnancy through community-directed interventions: evidence from Akwa Ibom State, Nigeria. | Q35181614 | ||
| Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance | Q35452357 | ||
| Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea | Q35500954 | ||
| Costs and cost-effectiveness of malaria control interventions--a systematic review | Q35589032 | ||
| Global Call to Action: maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa. | Q35689995 | ||
| A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy | Q35741292 | ||
| Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective | Q35759333 | ||
| Perspectives of health care providers on the provision of intermittent preventive treatment in pregnancy in health facilities in Malawi | Q35759393 | ||
| Assessment of knowledge, attitude and practice about malaria and ITNs utilization among pregnant women in Shashogo District, Southern Ethiopia | Q35762391 | ||
| Malaria in pregnancy and the endemicity spectrum: what can we learn? | Q35868709 | ||
| The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. | Q35872624 | ||
| User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya | Q35960893 | ||
| The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women | Q35965229 | ||
| A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected | Q36006670 | ||
| Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial | Q36057593 | ||
| Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda | Q36094714 | ||
| Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. | Q36292865 | ||
| Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study | Q36461809 | ||
| Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op | Q36478633 | ||
| Costs and effects of the Tanzanian national voucher scheme for insecticide-treated nets | Q36517661 | ||
| Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda | Q36550488 | ||
| Diagnosing malaria in pregnancy: an update | Q36555631 | ||
| The effect of malaria transmission intensity on neonatal mortality in endemic areas | Q36576688 | ||
| Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight | Q36603993 | ||
| "There is no free here, you have to pay": actual and perceived costs as barriers to intermittent preventive treatment of malaria in pregnancy in Mali | Q36679237 | ||
| Epidemiology and burden of malaria in pregnancy | Q36717617 | ||
| Malaria in pregnancy: pathogenesis and immunity | Q36717621 | ||
| Reducing the burden of malaria in pregnancy by preventive strategies | Q36717628 | ||
| From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy | Q36717635 | ||
| The economics of malaria in pregnancy--a review of the evidence and research priorities | Q36717638 | ||
| A model of parity-dependent immunity to placental malaria. | Q36737343 | ||
| Perceptions and practices for preventing malaria in pregnancy in a peri-urban setting in south-western Uganda | Q36796835 | ||
| Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy | Q36843561 | ||
| Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children | Q36876420 | ||
| Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study | Q37048282 | ||
| Ownership and use of insecticide-treated nets during pregnancy in sub-Saharan Africa: a review | Q37071867 | ||
| Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment | Q37211417 | ||
| Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda | Q37211931 | ||
| Perception and attitudes towards preventives of malaria infection during pregnancy in Enugu State, Nigeria | Q37261446 | ||
| Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania | Q37262379 | ||
| Cost effectiveness of intermittent screening followed by treatment versus intermittent preventive treatment during pregnancy in West Africa: analysis and modelling of results from a non-inferiority trial | Q37280776 | ||
| Perceptions of intermittent preventive treatment of malaria in pregnancy (IPTp) and barriers to adherence in Nasarawa and Cross River States in Nigeria | Q37361469 | ||
| Assessing the burden of pregnancy-associated malaria under changing transmission settings | Q37414302 | ||
| Prevention and management of malaria during pregnancy: findings from a comparative qualitative study in Ghana, Kenya and Malawi | Q37418029 | ||
| Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi | Q37449795 | ||
| Psychosocial, behavioural and health system barriers to delivery and uptake of intermittent preventive treatment of malaria in pregnancy in Tanzania - viewpoints of service providers in Mkuranga and Mufindi districts | Q37501100 | ||
| Mobile phones improve antenatal care attendance in Zanzibar: a cluster randomized controlled trial | Q37502796 | ||
| Perceptions of malaria in pregnancy and acceptability of preventive interventions among Mozambican pregnant women: implications for effectiveness of malaria control in pregnancy | Q37548377 | ||
| Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis | Q37607325 | ||
| Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria | Q38136762 | ||
| A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana | Q38387621 | ||
| Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis | Q38596372 | ||
| Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women | Q38850820 | ||
| Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention | Q38851261 | ||
| Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities | Q38874408 | ||
| Intermittent preventive treatment of malaria in pregnancy: the incremental cost-effectiveness of a new delivery system in Uganda. | Q38876208 | ||
| Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine | Q38920997 | ||
| Prevention of malaria in pregnancy: a fork in the road? | Q38944061 | ||
| Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. | Q39023255 | ||
| P921 | main subject | pregnancy-associated malaria | Q7239883 |
| malaria | Q12156 | ||
| malaria prevention | Q93598033 | ||
| P577 | publication date | 2018-01-30 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Prevention of malaria in pregnancy |
| Q92575648 | A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women |
| Q57459025 | An analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa |
| Q92375746 | Antimalarial drug resistance in Africa: the calm before the storm? |
| Q91341743 | Back to chloroquine for malaria prophylaxis in pregnancy? |
| Q102322365 | Back to school for malaria prevention: a new tool in the era of malaria elimination? |
| Q50207341 | Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem |
| Q64134489 | Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda |
| Q60343713 | Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial |
| Q101155591 | Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data |
| Q89980597 | Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West Cameroon |
| Q99569236 | Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs |
| Q92684763 | Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis |
| Q92580319 | Effectiveness of intermittent screening and treatment for the control of malaria in pregnancy: a cluster randomised trial in India |
| Q92230256 | Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, o |
| Q91214784 | Estimating malaria burden among pregnant women using data from antenatal care centres in Tanzania: a population-based study |
| Q58609032 | Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled |
| Q53821185 | Malaria in pregnancy: a call for a safe, efficient, and patient-centred approach to first-trimester treatment. |
| Q62488463 | Mefloquine for preventing malaria in pregnant women |
| Q51737259 | Mefloquine for preventing malaria in pregnant women. |
| Q98176809 | Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa |
| Q102322366 | Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses |
| Q89898815 | Recombinase polymerase amplification and lateral flow assay for ultrasensitive detection of low-density Plasmodium falciparum infection from controlled human malaria infection studies and naturally acquired infections |
| Q64232067 | Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug! |
| Q98292662 | Systematic review of microeconomic analysis of pregnancy-associated malaria |
| Q64077095 | Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole |
| Q62486720 | Trends in comparative efficacy and safety of malaria control interventions for maternal and child health outcomes in Africa: a study protocol for a Bayesian network meta-regression exploring the effect of HIV and malaria endemicity spectrum |
| Q90364622 | Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016 |
| Q92707837 | Use of a highly-sensitive rapid diagnostic test to screen for malaria in pregnancy in Indonesia |
Search more.